- Associated Press•19 days ago
The San Diego-based company said it had a loss of 99 cents per share. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for ...
- PR Newswire•19 days ago
Mirati Therapeutics Reports Financial Results And Provides Business Update For The Fourth Quarter And Full Year 2016
SAN DIEGO, March 9, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) ("the Company," "we," "our," "us," or "Mirati") today reported financial ...
- PR Newswire•last month
SAN DIEGO, Feb. 13, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that Charles M. Baum, M.D, Ph.D., President and CEO of Mirati, will provide a corporate overview during ...
MRTX : Summary for Mirati Therapeutics, Inc. - Yahoo Finance
Mirati Therapeutics, Inc. (MRTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.75 x 300|
|Ask||5.65 x 800|
|Day's Range||5.10 - 5.20|
|52 Week Range||4.40 - 24.43|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.24|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|